Alpha 1 Biomedicals Thymosin alpha 1
Executive Summary
Granted orphan drug status by FDA for the treatment of chronic active hepatitis B. A synthetic hormone that modulates the immune system. Thymosin alpha 1 currently is in (ITALICS)Phase III(END ITALICS) clinical trials at three U.S. sites for the treatment of hepatitis B and also is being evaluated as a treatment for head and neck cancer and as an adjuvant to chemotherapy treatment.